Home Featured Page 3

Featured

PT347 – Christopher Koddermann – Rescheduling Psilocybin, Patents and IP, and The Entourage Effect

Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health

atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update

FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study

MindMed Board of Directors Approves Reverse Share Split

COMPASS Pathways plc announces second quarter 2022 financial results and business...

MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Canadian Patent Grant Strengthens Small Pharma’s International Position

Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough...

Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health...

Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A

Opening the Mushroom Pharmacopeia: The Case of Norbaeocystin

PT343 – Soren Shade – Kratom and Anti-Prohibition: Lessons Learned and...

COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord...

1 234...150 Page 3 of 150

EDITOR PICKS

PT347 – Christopher Koddermann – Rescheduling Psilocybin, Patents and IP, and...

Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health

atai Life Sciences Reports Second Quarter 2022 Financial Results & Business...

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

How to Get DMT: Obtaining the Spirit Molecule

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

PT347 – Christopher Koddermann – Rescheduling Psilocybin, Patents and IP, and The Entourage Effect

Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health

atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update

FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study

MindMed Board of Directors Approves Reverse Share Split

COMPASS Pathways plc announces second quarter 2022 financial results and business...

MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

Canadian Patent Grant Strengthens Small Pharma’s International Position

Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough...

Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health...

Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A

Opening the Mushroom Pharmacopeia: The Case of Norbaeocystin

PT343 – Soren Shade – Kratom and Anti-Prohibition: Lessons Learned and...

COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord...

EDITOR PICKS

PT347 – Christopher Koddermann – Rescheduling Psilocybin, Patents and IP, and...

Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health

atai Life Sciences Reports Second Quarter 2022 Financial Results & Business...

POPULAR POSTS

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

How to Get DMT: Obtaining the Spirit Molecule

POPULAR CATEGORY